| CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells AL Chang, J Miska, DA Wainwright, M Dey, CV Rivetta, D Yu, D Kanojia, ... Cancer research 76 (19), 5671-5682, 2016 | 598 | 2016 |
| IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival DA Wainwright, IV Balyasnikova, AL Chang, AU Ahmed, KS Moon, ... Clinical cancer research 18 (22), 6110-6121, 2012 | 492 | 2012 |
| Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy B Auffinger, AL Tobias, Y Han, G Lee, D Guo, M Dey, MS Lesniak, ... Cell Death & Differentiation 21 (7), 1119-1131, 2014 | 397 | 2014 |
| The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence B Auffinger, D Spencer, P Pytel, AU Ahmed, MS Lesniak Expert review of neurotherapeutics 15 (7), 741-752, 2015 | 318 | 2015 |
| Blood‐brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging Y Cheng, Q Dai, RA Morshed, X Fan, ML Wegscheid, DA Wainwright, ... Small 10 (24), 5137-5150, 2014 | 294 | 2014 |
| HIF-1α is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of Tregs in glioblastoma J Miska, C Lee-Chang, A Rashidi, ME Muroski, AL Chang, ... Cell Reports 27 (1), 226-237. e4, 2019 | 291 | 2019 |
| Graphene oxide incorporated functional materials: A review H Ahmad, M Fan, D Hui Composites Part B: Engineering 145, 270-280, 2018 | 287 | 2018 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 220 | 2022 |
| Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells C Cole, J Qiao, T Kottke, RM Diaz, A Ahmed, L Sanchez-Perez, G Brunn, ... Nature medicine 11 (10), 1073-1081, 2005 | 195 | 2005 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 193 | 2024 |
| A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma AU Ahmed, MA Tyler, B Thaci, NG Alexiades, Y Han, IV Ulasov, ... Molecular pharmaceutics 8 (5), 1559-1572, 2011 | 162 | 2011 |
| Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma AU Ahmed, B Thaci, NG Alexiades, Y Han, S Qian, F Liu, IV Balyasnikova, ... Molecular Therapy 19 (9), 1714-1726, 2011 | 160 | 2011 |
| Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells AR Bateman, KJ Harrington, T Kottke, A Ahmed, AA Melcher, MJ Gough, ... Cancer research 62 (22), 6566-6578, 2002 | 155 | 2002 |
| Macrophages orchestrate the immune response to tumor cell death MJ Gough, AA Melcher, A Ahmed, MR Crittenden, DS Riddle, ... Cancer Research 61 (19), 7240-7247, 2001 | 147 | 2001 |
| Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial J Fares, AU Ahmed, IV Ulasov, AM Sonabend, J Miska, C Lee-Chang, ... The Lancet Oncology 22 (8), 1103-1114, 2021 | 145 | 2021 |
| Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression D Yu, OF Khan, ML Suvà, B Dong, WK Panek, T Xiao, M Wu, Y Han, ... Proceedings of the National Academy of Sciences 114 (30), E6147-E6156, 2017 | 135 | 2017 |
| Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors IV Balyasnikova, MS Prasol, SD Ferguson, Y Han, AU Ahmed, M Gutova, ... Molecular Therapy 22 (1), 140-148, 2014 | 134 | 2014 |
| Mutator phenotype of BCR–ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase β Y Canitrot, D Lautier, G Laurent, M Frechet, A Ahmed, AG Turhan, ... Oncogene 18 (17), 2676-2680, 1999 | 133 | 1999 |
| Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth AU Ahmed, RL Schmidt, CH Park, NR Reed, SE Hesse, CF Thomas, ... JNCI: Journal of the National Cancer Institute 100 (22), 1606-1629, 2008 | 131 | 2008 |
| The art of gene therapy for glioma: a review of the challenging road to the bedside A Tobias, A Ahmed, KS Moon, MS Lesniak Journal of Neurology, Neurosurgery & Psychiatry 84 (2), 213-222, 2013 | 128 | 2013 |